In light of these trends, it's become necessary for biopharmaceutical companies to explore digital strategies in order to connect with target consumer and physician audiences at both a European and global level - however, they face a myriad of challenges in terms of regulations, process, and internal understanding.
To encourage innovation and knowledge-sharing across the industry, Manhattan Research releases its 2008 European Opinion Leader Roundtable report - a collection of opinions and best practices on key e-marketing and sales topics from innovators at AstraZeneca, UCB Pharma, Shire Pharmaceuticals, and Across Health. The virtual discussion is led by Manhattan Research President Mark Bard.
"Biopharma companies in Europe - and globally as well - can no longer afford to ignore 'e' channels as viable and cost-effective ways to reach consumer and physician groups," said Mr. Bard, "The key opinion leaders in this roundtable are catalysts for digital innovation within their respective organizations and offer valuable lessons learned and best practices for marketing and sales teams."
European Opinion Leader Roundtable Summary
Mark Bard, Manhattan Research
John Fish, AstraZeneca
Jean-Pierre Henskens, UCB Pharma
Gene Miller, Shire Pharmaceuticals
Fonny Schenck, Across Health
- Web-Empowered Healthcare Consumers
- Facing Regulatory Challenges
- Patient Compliance & Digital Strategy
- Search Engine Marketing
- Physicians & Closed Loop Marketing
- Integration & Measurement
- E-marketing Lessons Learned
The roundtable report is available to download on the Manhattan Research website. Please visit: http://www.manhattanresearch.com/research/roundtables/european-roundtable-2008.aspx.
Manhattan Research European Study & Strategic Advisory Service Products
Manhattan Research offers two European market research study & strategic advisory services for the healthcare and biopharmaceutical companies.
Cybercitizen Health™ Europe is focused on how European consumers use new media and technology for health information and its impact on treatment and product decisions. The latest study was conducted in Q3 2008 among 4,079 consumers in the United Kingdom, Germany, Spain, Italy, France, Belgium, Sweden, the Netherlands, Poland, and Portugal. Cybercitizen Health™ Europe identifies and analyses the behaviour, attitudes, and demographics of the consumer population who use technology and the Internet for health purposes, as well as further segmenting the population by therapeutic area, technology utilisation, and motivation. For more information, visit http://www.manhattanresearch.com/products/consumer/ccheu.aspx
Taking the Pulse® Europe is focused on how physicians across Europe use new media and technology for professional purposes. The next study will be available at the end of Q4 2008. Last year's study was fielded among 1,000 physicians from the United Kingdom, Germany, Spain, Italy, and France. Taking the Pulse® Europe provides pharmaceutical and healthcare companies with key data and insight about the evolving nature of physician channel mix, media and technology usage, and healthcare information with the goal of helping companies understand how physicians across Europe access health information. For more information, visit http://www.manhattanresearch.com/products/physician/EUphysicians.aspx
In addition to the core data, subscribing clients have access to the Manhattan Research analyst team and the ability to request country-specific therapeutic and specialist segmentations.
About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a leading market research and advisory services firm for global pharmaceutical and healthcare companies. For more information, visit http://www.manhattanresearch.com.
About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.DecisionResourcesInc.com.